Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer

Immune checkpoint
DOI: 10.1007/s00262-025-03984-7 Publication Date: 2025-04-17T11:53:52Z